Deerfield Management EMBC Position
ActiveDeerfield Management increased their position in Embecta Corp. (EMBC) in Q4 2025, holding $32.7M worth of shares across 2,752,031 shares.
The position was first reported in Q4 2023 and has been tracked across 9 quarterly 13F filings.
Short interest stands at 11.3% of float with 6.5 days to cover, indicating significant bearish positioning against Deerfield's long thesis.
About Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Full company profile →Short Interest
11.3%
6.5 days to cover
Deerfield Management EMBC Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Increased | 2,752,031 | +131,610 | $32.7M |
| Q3 2025 | Decreased | 2,620,421 | -129,291 | $37.0M |
| Q2 2025 | Increased | 2,749,712 | +29,177 | $26.6M |
| Q1 2025 | Decreased | 2,720,535 | -550,000 | $34.7M |
| Q4 2024 | Increased | 3,270,535 | +540,192 | $67.5M |
| Q3 2024 | Increased | 2,730,343 | +4,208 | $38.5M |
| Q2 2024 | Held | 2,726,135 | — | $34.1M |
| Q1 2024 | Increased | 2,726,135 | +1,341,296 | $36.2M |
| Q4 2023 | New | 1,384,839 | +1,384,839 | $26.2M |
Frequently Asked Questions
Does Deerfield Management own EMBC?
Yes. As of Q4 2025, Deerfield Management holds 2,752,031 shares of Embecta Corp. (EMBC) valued at $32.7M. This data comes from their SEC 13F filing.
How many hedge funds own EMBC?
1 specialist biotech hedge fund currently holds EMBC. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Deerfield Management first buy EMBC?
Deerfield Management's position in EMBC was first reported in Q4 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Deerfield Management's EMBC position increasing or decreasing?
Deerfield Management increased their EMBC position in the most recent quarter, adding 131,610 shares.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
EMBCCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Deerfield ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →